DCM
RVMDW icon

Driehaus Capital Management’s Revolution Medicines Inc Warrant RVMDW Stock Holding History

Driehaus Capital Management’s Portfolio RVMDW Stock Details RVMDW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$34.8K Sell
20,000
-115,000
-85% -$223K ﹤0.01% 355
2025
Q4 		$127K Hold
135,000
– – ﹤0.01% 392
2025
Q3 		$40.5K Hold
135,000
– – ﹤0.01% 429
2025
Q2 		$36.3K Hold
135,000
– – ﹤0.01% 414
2025
Q1 		$5.13K Hold
135,000
– – ﹤0.01% 393
2024
Q4 		$20.3K Buy
+135,000
New +$39.9K ﹤0.01% 379

Other funds holding RVMDW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LC
Lunate Capital Al Maryah Island, Abu Dhabi, United Arab Emirates $196M AUM 84.21% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Driehaus Capital Management's RVMDW Position: Q1 2026 in Review

Driehaus Capital Management reduced its Revolution Medicines Inc Warrant (RVMDW) stake by 85% in Q1 2026, selling an estimated $223K and leaving 20,000 shares worth $34.8K. The position accounts for ﹤0.01% of the portfolio, ranked #355.

Driehaus Capital Management first reported a position in RVMDW in Q4 2024 and has held it in 6 quarters since. The position peaked at $127K in Q4 2025. 23 funds tracked by Wall St. Rank hold RVMDW as of Q1 2026.

  • Driehaus Capital Management held 20,000 shares of Revolution Medicines Inc Warrant worth $34.8K as of Q1 2026.
  • Driehaus Capital Management sold 115,000 Revolution Medicines Inc Warrant shares in Q1 2026, an estimated $223K.
  • Revolution Medicines Inc Warrant made up ﹤0.01% of Driehaus Capital Management's portfolio in Q1 2026, its #355 holding.
  • Driehaus Capital Management first reported a position in Revolution Medicines Inc Warrant in Q4 2024 and has held it in 6 quarters since.
  • Driehaus Capital Management's Revolution Medicines Inc Warrant position peaked at $127K in Q4 2025.
  • 23 funds tracked by Wall St. Rank held Revolution Medicines Inc Warrant as of Q1 2026.

Based on Driehaus Capital Management's 13F filing for Q1 2026, filed 15 May 2026.